Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency.
Inoue K, Tomomasa D, Nakagama Y, Takeuchi H, Tanaka Y, Tanimoto K, Kamiya T, Isoda T, Takagi M, Tanaka K, Yoshifuji K, Miwa Y, Ohnishi H, Okada S, Mori T, Yasuda S, Kido Y, Morio T, Kanegane H.
Inoue K, et al. Among authors: tanaka k.
J Infect Chemother. 2024 Dec 5:S1341-321X(24)00324-6. doi: 10.1016/j.jiac.2024.12.006. Online ahead of print.
J Infect Chemother. 2024.
PMID: 39645037